New device aims to seal brain aneurysms before they burst

NCT ID NCT06761365

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests a new device called the LuSeed Aneurysm Embolization System for treating unruptured brain aneurysms. The device is designed to block blood flow into the aneurysm, reducing the risk of rupture. About 30 adults aged 18-80 with unruptured saccular aneurysms will be enrolled across up to 10 medical centers in the EU. The main goals are to check if the device is safe and can be successfully placed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEURYSM CEREBRAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Jan Mikulicz-Radecki University Clinical Hospital in Wrocław

    NOT_YET_RECRUITING

    Wroclaw, Poland

  • Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz

    RECRUITING

    Lodz, Poland

  • Sheba Medical Center

    RECRUITING

    Tel Litwinsky, Israel

  • The University Medical Center Hamburg-Eppendorf

    RECRUITING

    Hamburg, Germany

  • UCK Katowice

    RECRUITING

    Katowice, Poland

  • University Hospital St. Ivan Rilski

    RECRUITING

    Sofia, Bulgaria

More trials for these conditions

Other studies related to the condition(s) this trial covers.